How is the global precision medicine market shaping up?, Pg8

Key Highlights:

• Precision biotherapeutics uses genetic science, molecular biology, and data analytics to design therapies that address the root cause of diseases.
• Non-communicable diseases account for approximately 65% of deaths in India, highlighting the need for precision medicine.
• The Department of Biotechnology has identified precision biotherapeutics as a key focus area.
• The global precision medicine market is projected to exceed $22 billion by 2027.

Detailed Insights:

• Precision biotherapeutics involves tailoring medical interventions based on an individual's unique genetic, molecular, and cellular profile.
• Genomic research programs like IndiGen and GenomeIndia can be leveraged to customize treatments based on local genetic profiles.
• Indian institutions such as the Institute of Genomics and Integrative Biology are mapping genetic diversity to understand disease susceptibility.
• A clear regulatory framework is needed to guide the use of gene and cell therapies in India, as current guidelines have limitations.
• Ethical and privacy concerns surrounding the use of genetic data need to be addressed through strict data protection and consent frameworks.

Key Concepts Involved:

• Genomics: The study of an organism's complete set of DNA, including its genes.
• Monoclonal antibodies: Laboratory-produced molecules engineered to bind to specific disease targets.
• Biosimilars: Biological products that are similar to already approved biological products.